Skip to main content
Premium Trial:

Request an Annual Quote

DNA Dilemma

A reader writes in to The New York Times Magazine to ask about the ethics of DNA testing — the reader doesn't want to be tested, citing privacy concerns, but the reader's siblings want to learn about their genealogy through DNA testing. Ariel Kaminer, the Times' ethics columnist, recommends first considering whether "genetic testing [is] even worthwhile." She cites a report from the US Government Accountability Office that found many direct-to-consumer genetic tests have "inaccurate results and [make] exaggerated claims." As for privacy concerns, Kaminer notes that companies can't sell or use customers' data without permission, "but the fine print on those consent forms goes by so quickly that it can be hard to follow." In the end, Kaminer recommends educating the siblings about the limitations of testing and the significance of the consent forms. "Your siblings should consider how their actions affect you, but ultimately their genes are their own, however strong the family resemblance," she says.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.